Daiwa Securities Group Inc. - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 99 filers reported holding KEROS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$40.0%1110.0%0.00%
Q2 2023$4
-20.0%
1110.0%0.00%
Q1 2023$50.0%1110.0%0.00%
Q4 2022$5
-99.8%
111
+38.8%
0.00%
Q3 2022$3,000
+50.0%
800.0%0.00%
Q2 2022$2,000
-50.0%
800.0%0.00%
Q1 2022$4,000
-20.0%
800.0%0.00%
Q4 2021$5,000
+66.7%
800.0%0.00%
Q3 2021$3,000
+50.0%
80
+81.8%
0.00%
Q2 2021$2,000
-33.3%
440.0%0.00%
Q1 2021$3,0000.0%440.0%0.00%
Q4 2020$3,000440.00%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 407,633$12,995,3405.15%
Opaleye Management Inc. 360,400$11,489,5523.74%
Parkman Healthcare Partners LLC 298,475$9,515,3831.74%
BRAIDWELL LP 1,357,309$43,271,0111.37%
First Light Asset Management, LLC 421,438$13,435,4431.28%
Orbimed Advisors 1,514,734$48,289,7201.03%
Yiheng Capital Management, L.P. 554,151$17,666,3340.90%
Nantahala Capital Management 328,781$10,481,5380.90%
DAFNA Capital Management LLC 65,961$2,102,8370.65%
EDBI Pte Ltd 10,105$322,1470.35%
View complete list of KEROS THERAPEUTICS INC shareholders